Currently Viewing:
The Academy of Managed Care Pharmacy (AMCP) Nexus 2018
Drug Market to See More Competition, Launch of Biosimilars in 2019
October 23, 2018
Dr Aimee Tharaldson Outlines Current Key Market Trends in Specialty Pharmacy
October 23, 2018
Dr Jane F. Barlow: How Curative, High-Cost Therapies Bring Challenges to the Reimbursement Landscape
October 23, 2018
Law to Curb Opioid Abuse Will Have Many Managed Care Priorities, Experts Say
October 23, 2018
Analysis Finds HIV Therapy Biktarvy Associated With Cost Savings Compared With Most Regimens
October 24, 2018
Dr Christopher Diehl Explains the Pharmacist's Role in Value-Based Models
October 24, 2018
Currently Reading
Dr Jennifer Graff on Using Real-World Evidence to Deliver High-Quality Care
October 24, 2018
Massachusetts Medicaid Finds CAR T-Cell Payment Solution While Waiting on CMS
October 25, 2018
Dan Mendelson: Healthcare Policy Changes Avalere Health Is Paying Attention To
October 25, 2018
Dr Kibum Kim on Precision Medicine in Managed Care
October 25, 2018
From Pathways to Pharmacy: Sharing Approaches to Value-Based Care
October 25, 2018
Dr Jane F. Barlow on How Curative, High-Cost Therapies Will Affect Patient OOP Costs
November 09, 2018
Dr Aimee Tharaldson: Recently Approved Specialty Drugs, Upcoming Approvals to Watch For
November 13, 2018
Dan Mendelson Discusses How Mergers and Acquisitions Are Affecting the Market
November 14, 2018
Dan Mendelson on the Trump Administration's Efforts to Lower Drug Prices
November 22, 2018
Dr Jane F. Barlow Discusses Potential New Reimbursement Models for New, High-Cost Therapies
November 27, 2018
Dan Mendelson's Expectations for Cross-Sector Mergers Like CVS, Aetna
November 28, 2018
Specialty Drug Approvals Dr Aimee Tharaldson is Looking Out for in 2019
November 29, 2018
Dan Mendelson on the Shift to Value-Based Care and Prescribing Patterns
December 22, 2018

Dr Jennifer Graff on Using Real-World Evidence to Deliver High-Quality Care

Real-world evidence helps to inform high-quality care in a number of different ways, and health information technology has really improved the quality and the caliber of real-world data available, explained Jennifer Graff, PharmD, vice president of comparative effectiveness research, National Pharmaceutical Council.


Real-world evidence helps to inform high-quality care in a number of different ways, explained Jennifer Graff, PharmD, vice president of comparative effectiveness research, National Pharmaceutical Council.

Transcript

How does real-world evidence help with informing and delivering high-quality care?

Real-world evidence helps to inform high-quality care in a number of different ways. It can help from just understanding what patients are doing. Are they adhering to their medication? It helps us understand what are the best care mechanisms, what are evidence-based care pathways that we need it set up. It helps us understand which patients are most likely to be appropriate for special care management programs, identify patients that are more likely to have better outcomes or worse side effects, and it also allows us to move into value-based payment for value-based contracts. So, real-world evidence is that crux of all the things that we do across the healthcare system.

How has the uptake of health information technology impacted the use of real-world evidence?

Health information technology has really improved the quality and the caliber of real-world data that was available. Previously, it was just based upon claims. Now, it’s based upon much richer clinical data from electronic health records, mobile apps, and other sources. So, by understanding all of this, we have much more granularity to understand how patients are doing and what works best for them.

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!